JNJ vs PODD
By Alex · Tickerpine
Johnson & Johnson vs Insulet Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | PODD |
|---|---|---|
| Price | $260.86 | $145.06 |
| Market cap | $628.65B | $10.06B |
| P/E ratio | 30.3 | 27.2 |
| ROE | 25.74% | 26.02% |
| Profit margin | 21.48% | 12.29% |
| Revenue growth | 6.60% | 23.50% |
| Dividend yield | 2.05% | — |
| Beta | 0.23 | 1.09 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs PODD in plain English
- JNJ is the bigger company — about 62.5× the market cap of PODD.
- PODD is cheaper on earnings (P/E 27.2 vs 30.3).
- PODD earns a higher return on equity (26% vs 26%).
- PODD is growing revenue faster (24% vs 7%).
- JNJ pays a dividend (2.05%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
PODD return calculator
See what $1,000 in Insulet Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.